(Q73026356)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Prostanoid biosynthesis in patients with cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

B Strandvik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E Svensson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H W Seyberth

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 December 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

Prostaglandins, Leukotrienes and Essential Fatty Acids

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

419-425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

Identification of the cystic fibrosis gene: chromosome walking and jumping

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Pancreatic function and gene deletion F508 in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Cystic fibrosis. Channelling our thoughts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Regulation of ion channels by ABC transporters that secrete ATP.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Serum fatty acid profiles in cystic fibrosis patients and their parents.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Increase of bradykinin-stimulated arachidonic acid release in a delta F508 cystic fibrosis epithelial cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

The enzymatic formation of prostaglandin E2 from arachidonic acid prostaglandins and related factors 32

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Determination of peripheral plasma prostanoid concentration: an unreliable index of 'in vivo' prostanoid activity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Measurement of renal and non-renal eicosanoid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Respiratory studies in children. IX. Relationships between mechanical properties of the lungs, lung volumes and ventilatory capacity in healthy children 7-15 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Effect on renal function of essential fatty acid supplementation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Excretion of primary prostanoids and their metabolites during acute volume expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

A simplified analysis of fatty acids in serum phospholipids using Sep-Pak cartridges

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Simultaneous determination of prostanoids in plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Inhibition of prostaglandin synthesis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Estimated rate of prostacyclin secretion into the circulation of normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Paired analysis of urinary thromboxane B2 metabolites in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Generation and metabolism of leukotrienes in granulocytes of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Defective inhibition by dexamethasone of leukotriene B4 and C4 production by leukocytes in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Vitamin E deficiency increases serum thromboxane A2, platelet arachidonate and lipid peroxidation in male Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Activity of phospholipase A in serum from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Enhanced dexamethasone resistance in cystic fibrosis cells: potential use for heterozygote detection and prenatal diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Cystic fibrosis patients' B-lymphocyte response is resistant to the in vitro enhancing effect of corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Decreased inhibition of platelet aggregation by PGE1 in children with cystic fibrosis and their parents

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Platelet hyperaggregability in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

Characterization of the ATP-dependent leukotriene C4 export carrier in mastocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990125-8

7 January 2021

10.1016/S0952-3278(96)90125-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014220%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference